Orwin John Ainsider trades
In SEC Form 4 filings, Orwin John A is listed as Director of Anaptysbio, Inc (ANAB) and Director of First Tracks Biotherapeutics, Inc. (TRAX). Orwin John A reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 17.
Companies and roles
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-17
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ANABAnaptysbio, Inc | Sep 15 | Sep 17 | M | 1,300 | $0.00 | $0 | 17,995 | No | Form 4 |
| ANABAnaptysbio, Inc | Sep 15 | Sep 17 | M · derivative | 1,300 | $0.00 | $0 | not reported | No | Form 4 |
| TRAXFirst Tracks Biotherapeutics, Inc. | Sep 15 | Sep 17 | M | 1,300 | $0.00 | $0 | 17,995 | No | Form 4 |
| TRAXFirst Tracks Biotherapeutics, Inc. | Sep 15 | Sep 17 | M · derivative | 1,300 | $0.00 | $0 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.